Products & Services
5-FU Therapeutic Implant
Adjuvant CGP 11637 Toxicity Studies Results Conducted
Adjuvant CGP 11637 Toxicity Studies Results Conducted in European FA
AL 721
Sites
Novartis Pharmanalytica SA
Audited
Country
Switzerland
City
Locarno
Address
Via Serafino Balestra 31, 6600
Novartis Ringaskiddy Ltd
Audited
Country
Ireland
City
Cork
Country
Germany
City
Marburg
Address
Marburg. DE, 35
Country
United Kingdom
City
Speke
Address
L24 9GR. LIVERPOOL. United Kingdom
Country
Italy
Address
53018. SOVICILLE. Italy